CLTRN
Collectrin
Also known as: CLTRN_HUMAN, NX17, TMEM27
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9HBJ8
- Gene
- CLTRN
- Ensembl
- ENSG00000147003
- Chromosome
- X
- Canonical length
- 222 aa
- Protein class
- Metabolic proteins, Predicted membrane proteins, Transporters
- Subcellular location
- Endoplasmic reticulum,Vesicles
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes a type 1 transmembrane protein that is important for trafficking amino acid transporters to the apical brush border of proximal tubules. The encoded protein binds to amino acid transporters and regulates their expression on the plasma membrane. It also plays a role in controlling insulin exocytosis by regulating formation of the SNARE (soluble N-ethylmaleimide-sensitive-factor attachment protein receptor) complex in pancreatic beta cells. The extracellular domain of the encoded protein may be cleaved and shed from the plasma membrane specifically in pancreatic beta cells. [provided by RefSeq, Jun 2013]
Canonical amino-acid sequenceUniProt
222 residues, UniProt reviewed canonical sequence.
>Q9HBJ8|CLTRN
1 MLWLLFFLVT AIHAELCQPG AENAFKVRLS IRTALGDKAY AWDTNEEYLF KAMVAFSMRK
61 VPNREATEIS HVLLCNVTQR VSFWFVVTDP SKNHTLPAVE VQSAIRMNKN RINNAFFLND
121 QTLEFLKIPS TLAPPMDPSV PIWIIIFGVI FCIIIVAIAL LILSGIWQRR RKNKEPSEVD
181 DAEDKCENMI TIENGIPSDP LDMKGGHIND AFMTEDERLT PLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CLTRN can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.45
- Highest tissue expression
- 454 nTPM
Expression across tissuesHPA
Tissue
- kidney: 454 nTPM
- liver: 58 nTPM
- choroid plexus: 39 nTPM
- stomach: 10 nTPM
- parathyroid gland: 9.9 nTPM
- pancreas: 5.1 nTPM
Single-cell type
- proximal tubule cells: 53 nCPM
- choroid plexus epithelial cells: 18 nCPM
- loop of henle epithelial cells: 11 nCPM
- renal collecting duct intercalated cells: 6 nCPM
- renal collecting duct principal cells: 5 nCPM
- podocytes: 4.6 nCPM
Immune cell
- naive CD4 T-cell: 0.6 nTPM
- MAIT T-cell: 0.3 nTPM
- memory CD4 T-cell: 0.2 nTPM
- naive B-cell: 0.2 nTPM
- naive CD8 T-cell: 0.2 nTPM
- T-reg: 0.2 nTPM
Brain region
- choroid plexus: 37 nTPM
- white matter: 2.5 nTPM
- cerebellum: 2 nTPM
- hippocampal formation: 2 nTPM
- medulla oblongata: 2 nTPM
- cerebral cortex: 1.9 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.75
- gnomAD pLI
- 0
- DepMap mean gene effect
- 0.02
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- calcium-ion regulated exocytosis
- insulin secretion involved in cellular response to glucose stimulus
- positive regulation of amino acid transport
- positive regulation of L-proline import across plasma membrane
- SNARE complex assembly
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CLTRN in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CLTRN as an antibody target. Whether an autoantibody or antibody against CLTRN could matter depends on whether native CLTRN is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CLTRN is annotated at the cell surface, where native CLTRN is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label CLTRN as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...